CCF: Cleveland Clinic Foundation; ECOG PS: Eastern Cooperative Oncology Group Performance Score; IKCWG: International Kidney Cancer Working Group; MSKCC: Memorial Sloan–Kettering Cancer Center.
Patients with mRCC and an asymptomatic and resectable primary tumor in place should be considered for CN if they have a favorable or intermediate MSKCC risk ... non-clear-cell RCC, a pretreatment ...
Hosted on MSN2mon
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy RecordKotecha, MD, of Memorial Sloan Kettering Cancer Center (MSKCC) in New York City ... further evaluation of ALLO-316 in CD70-positive RCC [renal cell carcinoma] and other CD70-positive malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback